Goetzl et al. found that, compared to those isolated from the controls, the astrocyte-derived exosomes from AD patients contained significantly higher levels of β-site amyloid precursor protein-cleaving enzyme 1 (BACE-1) and amyloid precursor protein (APP) [137]. This evidence concerns the gene BACE1 and Alzheimer disease.